Gene · 2530
FUT8: fucosyltransferase 8
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. FUT8: fucosyltransferase 8. Genes, record 2530. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2530
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9BYC5 | Alpha-(1,6)-fucosyltransferase | 575 | 14 | Ensembl, GeneID, HGNC |
Source UniProt
Patents95
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 46760 | Q9BYC5 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 46761 | Q9BYC5 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 46762 | Q9BYC5 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 7815 | Q9BYC5 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 7901 | Q9BYC5 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 1627 | Q9BYC5 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 1627 | Q9BYC5 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 7901 | Q9BYC5 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 7815 | Q9BYC5 | Espacenet |
| WO 2025093745 A1 | 2025-05-08 | 19 | Q9BYC5 | Espacenet |
1 to 10 of 95
See all 95 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants769
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | FUT8 papers | Newest fiscal year |
|---|---|---|---|
| R01DK099551 | New Congenital Disorders of Glycosylation: Therapy and Models | 5 | 2025 |
| P30CA051008 | Georgetown University Lombardi Comprehensive Cancer Center Support Grant | 4 | 2025 |
| P30DK123704 | MUSC Digestive Disease Research Core Center | 4 | 2025 |
| R24GM137782 | National Glycoscience Resource- CCRC Service and Training - NGlycoR@CCRC | 4 | 2025 |
| P30DK040561 | Boston Area Nutrition Obesity Research Center (NORC) | 3 | 2025 |
| P50CA058223 | SPORE in Breast Cancer | 3 | 2025 |
| R35GM119850 | Unraveling the mammalian secretory pathway through systems biology and algorithm development | 3 | 2025 |
| T32GM132055 | Cellular, Biochemical and Molecular Sciences Training Program | 3 | 2025 |
| P30AI027763 | UCSF-Bay Area Center for AIDS Research | 2 | 2025 |
| P30AI027767 | UAB Center for AIDS Research (CFAR) | 2 | 2025 |
1 to 10 of 769Source NIH's project files
See all 769 nih grantsPapers1,343
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Correction to: FUT8-Dependent Core Fucosylation: Essential for Platelet Function and a Target in Thrombosis. | Arterioscler Thromb Vasc Biol | 2026 | 42777065 | PubTator, text mining | PubMed |
| Tumor-cell HMGB1 restrains CD8+ T-cell immunity during conventional fractionated radiotherapy. | Cancer Lett | 2026 | 42762963 | PubTator, text mining | PubMed |
| CircFut8 Suppresses Bladder Cancer by Modulating SRSF9-Dependent Pre-mRNA Splicing. | J Gene Med | 2026 | 42643011 | PubTator, text mining | PubMed |
| Diagnosis of Congenital Disorders of Glycosylation Type II Subtypes Through Comprehensive N-Glycan Profiling by Mass Spectrometry. | Int J Mol Sci | 2026 | 42511652 | PubTator, text mining | PubMed |
| Integrated Single-Cell and Bulk Transcriptomic Analyses Identify a B Cell- and Plasma Cell-Associated Prognostic Signature and a Candidate Tumor-Suppressive Role for FUT8 in Ovarian Cancer. | Genes (Basel) | 2026 | 42510824 | PubTator, text mining | PubMed |
| Transcriptional Scenario of Altered Glycosylation in HPV-Associated Cervical Cancer. | Indian J Clin Biochem | 2026 | 42500337 | PubTator, text mining | PubMed |
| Molecular Feasibility of Gene Sequencing on Lymph Node Fine-Needle Cytology Samples of Non-Hodgkin Lymphoma. | Int J Mol Sci | 2026 | 42450228 | PubTator, text mining | PubMed |
| Integrated Glycoproteomics Identifies Dynamic IgA1 N-Glycosylation and FUT8 as a Functional Mediator in Multiple Myeloma. | Hematol Oncol | 2026 | 42364120 | PubTator, text mining | PubMed |
| Integrative Analysis of Glycosylation-Related Genes Reveals Prognostic Subtypes, Immune Evasion, and Therapeutic Vulnerabilities in Lung Adenocarcinoma. | Oncol Res | 2026 | 42358820 | PubTator, text mining | PubMed |
| Cross-species systems analysis distinguishes inflammatory remodeling from primary mucus secretory failure in inflammatory bowel disease. | Front Immunol | 2026 | 42344920 | PubTator, text mining | PubMed |
1 to 10 of 1,343
See all 1,343 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/2530
GET https://conductscience.org/api/genes/v1/2530/patents?page=2